Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III

American Heart Journal

Volumn 155, Issue 1, 2008, Pages 108-113

  Miyazawa, Akiyoshi ^a   Ako, Junya ^a   Hongo, Yoichiro ^a   Hur, Seung Ho ^a   Tsujino, Ichizo ^a   Courtney, Brian K ^a   Hassan, Ali H M ^a   Kandzari, David E ^b   Honda, Yasuhiro ^a   Fitzgerald, Peter J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; ZOTAROLIMUS;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SIROLIMUS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 36849065425     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.08.008     Document Type: Article

References (15)

1. Kandzari D.E., Leon M.B., Popma J.J., et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 2440-2447
2. Ako J., Morino Y., Honda Y., et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46 (2005) 1002-1005
3. Kataoka T., Grube E., Honda Y., et al. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE). Circulation 106 (2002) 1788-1793
4. Hoffmann R., Mintz G.S., Pichard A.D., et al. Intimal hyperplasia thickness at follow-up is independent of stent size: a serial intravascular ultrasound study. Am J Cardiol 82 (1998) 1168-1172
5. Wijns W., Fajadet J., Kuntz R., et al. ENDEAVOR II 12-month clinical results: a randomized, double-blind, multicenter trial of the ENDEAVOR ABT-578-eluting stent system for treatment of native coronary arteries. Am J Cardiol 96 (2005) 181h
6. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
7. Weissman N.J., Koglin J., Cox D.A., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
8. Stone G.W., Ellis S.G., Cox D.A., et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
9. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107 (2003) 381-383
10. Mintz G.S., Hong M.K., Raizner A.E., et al. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Am J Cardiol 95 (2005) 107-109
11. Degertekin M., Serruys P.W., Tanabe K., et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 108 (2003) 2747-2750
12. Hong M.K., Mintz G.S., Lee C.W., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
13. Tanabe K., Serruys P.W., Degertekin M., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents. Insights from the randomized TAXUS II Trial. Circulation 111 (2005) 900-905
14. Feres F., Costa Jr. J.R., and Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 68 (2006) 83-88
15. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202